LTI
GSK icon

Laffer Tengler Investments’s GSK GSK Stock Holding History

Laffer Tengler Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-310
Closed -$16.1K – 229
2015
Q2 		$16.1K Sell
310
-200,532
-100% -$11.3M ﹤0.01% 218
2015
Q1 		$11.6M Buy
+200,842
New +$11.5M 1.62% 22
2014
Q4 		– Sell
-185,718
Closed -$10.4M – 23
2014
Q3 		$10.7M Buy
185,718
+26,204
+16% +$1.61M 1.58% 23
2014
Q2 		$10.7M Buy
159,514
+22,903
+17% +$1.55M 1.64% 15
2014
Q1 		$9.12M Buy
+136,611
New +$9.24M 1.47% 15
2013
Q3 		– Hold
0
– – – 232

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Laffer Tengler Investments's GSK Position: Q3 2015 in Review

Laffer Tengler Investments sold out of GSK (GSK) in Q3 2015, closing a stake of 310 shares — an estimated $16.1K sold.

Laffer Tengler Investments first reported a position in GSK in Q1 2014 and held it in 5 quarters. The position peaked at $11.6M in Q1 2015. 707 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Laffer Tengler Investments reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Laffer Tengler Investments sold 310 GSK shares in Q3 2015, an estimated $16.1K.
  • Laffer Tengler Investments first reported a position in GSK in Q1 2014 and held it in 5 quarters.
  • Laffer Tengler Investments's GSK position peaked at $11.6M in Q1 2015.
  • 707 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Laffer Tengler Investments's 13F filing for Q3 2015, filed 6 Nov 2015.